A New Silver Complex with Ofloxacin – Preliminary Study

1. Uivaroşi V. Metal Complexes of Quinolone Antibiotics and Their Applications: An Update. Molecules. 2013,18:11153-11197.10.3390/molecules180911153Search in Google Scholar

2. Singh R, Debnath A, Masram DT, Rathore D. Synthesis and Biological Activities of Selected Quinolone-Metal Complexes. Research Journal of Chemical Sciences 2013;3:83-94.Search in Google Scholar

3. Psomas G, Kessissoglou DP. Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives. Dalton Trans 2013;42:6252-6276.10.1039/c3dt50268fSearch in Google Scholar

4. Akinremi CA, Obaleye JA, Amolegbe SA, Adediji JF, Bamigboye MO. Biological activities of some Fluoroquinolones-metal complexes. International Journal of Medicine and Biomedical Research 2012;1:24-34.10.14194/ijmbr.115Search in Google Scholar

5. Baenziger NC, Fox Jnr CL, Modak SL. The Structure of Silver Pefloxacin, an Antibiotic Related to Nalidixic Acid. Acta Crystallogr C 1986;42:1505–1509.10.1107/S0108270186091679Search in Google Scholar

6. Li YX, Chen ZF, Xiong RG, Xue Z, Ju HX, You XZ. A mononuclear complex of norfloxacin with silver(I) and its properties. Inorg Chem Commun 2003;6:819-822.10.1016/S1387-7003(03)00115-1Search in Google Scholar

7. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 2012;112:841-852.10.1111/j.1365-2672.2012.05253.x22324439Search in Google Scholar

8. El-Gamel NE. Silver(I) complexes as precursors to produce silver nanowires: structure characterization, antimicrobial activity and cell viability. Dalton Trans 2013;42:9884-9892.10.1039/C3DT33092CSearch in Google Scholar

9. Martínez-Abad A, Sánchez G, Lagaron JM, Ocio MJ. Ligands affecting silver antimicrobial efficacy on Listeria monocytogenes and Salmonella enterica. Food Chem. 2013;139:281-288.10.1016/j.foodchem.2013.01.01523561107Search in Google Scholar

10. Paiva IL, de Carvalho GSG, da Silva AD et al. Silver(I) complexes with symmetrical Schiff bases: Synthesis, structural characterization, DFT studies and antimycobacterial assays. Polyhedron. 2013;62:104-109.10.1016/j.poly.2013.06.031Search in Google Scholar

11. Soayed AA, Refaat HM, El-Din DAN. Metal complexes of moxifloxacin–imidazole mixed ligands: Characterization and biological studies. Inorganica Chimica Acta. 2013;406:230–240.10.1016/j.ica.2013.04.040Search in Google Scholar

12. Al-Omar MA. Ofloxacin, in Brittain HG (ed): Profiles of Drug Substances, Excipients, and Related Methodology. Academic Press, Burlington, 2009;265-298.10.1016/S1871-5125(09)34006-6Search in Google Scholar

13. Macias B, Villa M, Rubio I, Castineiras A, Borras J. Complexes of Ni (II) and Cu (II) with ofloxacin. Crystal structure of a new Cu (II) ofloxacin complex. J Inorg Biochem. 2001;84:163–170.10.1016/S0162-0134(01)00182-9Search in Google Scholar

14. Macias B, Villa MV, Sastre M, Castiñeiras A, Borras J. Complexes of Co(II) and Zn(II) with ofloxacin. Crystal structure of [Co(oflo)₂(MeOH)₂]·4MeOH. J Pharm Sci. 2002;91:2416–2423.10.1002/jps.1023412379927Search in Google Scholar

15. Sagdinc S, Bayari S. Spectroscopic studies on the interaction of ofloxacin with metals. J Mol Struct. 2004;691:107–113.10.1016/j.molstruc.2003.11.053Search in Google Scholar

16. Drevenšek P, Košmrlj J, Giester G, et al. X-ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones – racemic ofloxacin and its S-form, levofloxacin. J Inorg Biochem. 2006;100:1755–1763.10.1016/j.jinorgbio.2006.06.01116934331Search in Google Scholar

17. Vieira LMM, de Almeida MV, Lourenço MCS, Bezerra FAFM, Fontes APS. Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones. Eur J Med Chem. 2009;44:4107–4111.10.1016/j.ejmech.2009.05.00119482387Search in Google Scholar

18. Shaikh AR, Giridhar R, Megraud F, Yadav MR. Metalloantibiotics: Synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter Pylori. Acta Pharm. 2009;59:259–271.10.2478/v10007-009-0027-619819823Search in Google Scholar

19. Živec P, Perdih F, Turel I, Giester G, Psomas G. Different types of copper complexes with the quinolone antimicrobial drugs ofloxacin and norfloxacin: Structure, DNA- and albumin-binding. J Inorg Biochem. 2012;117:35–47.10.1016/j.jinorgbio.2012.08.00823078773Search in Google Scholar

20. Patel MN, Gandhi DS, Parmar PA. DNA interaction and in-vitro antibacterial studies of fluoroquinolone based platinum(II) complexes. Inorg Chem Commun. 2012;15:248–251.10.1016/j.inoche.2011.10.037Search in Google Scholar

21. Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex. Int J Pharm. 2013;440:273-282.10.1016/j.ijpharm.2012.05.04522659124Search in Google Scholar

22. Chen ZF, Yu LC, Zhong DC, Liang H, Zhu XH. An unprecedented 1D ladder-like silver(I) coordination polymer with ciprofloxacin, Inorg Chem Commun. 2006;9:839-843.Search in Google Scholar

23. Li MT, Sun JV, Sha JQ, Wu HB, Zhang EL, Zheng TY. An unprecedented Ag–pipemidic acid complex with helical structure: Synthesis, structure and interaction with CT-DNA, J Mol Struct. 2013;1045:29-34.Search in Google Scholar

24. Debnath A, Mogha NK, Masram DT. Metal Complex of the First-Generation Quinolone Antimicrobial Drug Nalidixic Acid: Structure and Its Biological Evaluation. Appl Biochem Biotechnol. 2015;175:2659-2667.10.1007/s12010-014-1450-925547815Search in Google Scholar

25. Dibbern HW, Müller RM, Wirbitzki E(eds): UV and IR Spectra, Pharmaceutical Substances (UV and IR) and Pharmaceutical and Cosmetic Excipients (IR). Editio Cantor Verlag, Aulendor, 2002;1102Search in Google Scholar

26. Salem H, Fada L, Khater W. Spectrofluorimetric Determination of Certain Fluoroquinolones Through Charge Transfer Complex Formation. American Journal of Pharmacology and Toxicology 2007;2: 18-25.10.3844/ajptsp.2007.18.25Search in Google Scholar

27. Gouvea LR, Garcia LS, Lachter DR, et al. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action. Eur J Med Chem. 2012;55:67-73.10.1016/j.ejmech.2012.07.00422835721Search in Google Scholar

28. Dorofeev VL. Infrared spectra and the structure of drugs of the fluoroquinolone group. Pharmaceutical Chemistry Journal (Khimiko-Farmatsevticheskii Zhurnal) 2004;38:45–49,2004.10.1007/s11094-005-0063-6Search in Google Scholar

29. Sadeek AS. Synthesis, thermogravimetric analysis, infrared, electronic and mass spectra of Mn(II), Co(II) and Fe(III) norfloxacin complexes. J Mol Struct. 2005;753:1-12.10.1016/j.molstruc.2005.06.011Search in Google Scholar

30. Sousa I, Claro V, Pereira JL, et al. Synthesis, characterization and antibacterial studies of a copper(II) levofloxacin ternary complex. J Inorg Biochem. 2012;110:64-71.10.1016/j.jinorgbio.2012.02.00322469700Search in Google Scholar

31. Coates G. Interpretation of Infrared Spectra, A Practical Approach, in Meyers RA (ed): Encyclopedia of Analytical Chemistry. John Wiley & Sons Ltd, Chichester, 2000;10815–10837.Search in Google Scholar

32. Refat MS. Synthesis and characterization of norfloxacin-transition metal complexes (group 11, IB): Spectroscopic, thermal, kinetic measurements and biological activity. Spectrochim Acta A Mol Biomol Spectrosc. 2007;68:1393-1405.10.1016/j.saa.2006.12.07817467332Search in Google Scholar

33. O’Neil MJ (ed): The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition. Whitehouse Station NJ Merck and Co Inc, 2001;1526.Search in Google Scholar

34. House JE - Inorganic chemistry. 2nd Edition, Academic Press, Elsevier Inc. All, 2013;570.Search in Google Scholar